Results for tag: "Achalasia Drug"

Achalasia is a rare disorder of the esophagus, which affects the ability of the esophagus to move food into the stomach. Treatment for achalasia typically involves medications, such as nitrates, calcium channel blockers, and botulinum toxin injections, as well as endoscopic or surgical procedures. The Achalasia Drug market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat a variety of gastrointestinal disorders. Achalasia drugs are used to relax the muscles of the esophagus, allowing food to pass more easily into the stomach. These drugs are typically administered orally or through injections. In addition, some achalasia drugs are used to reduce the amount of acid produced in the stomach, which can help reduce symptoms of achalasia. The Achalasia Drug market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include AstraZeneca, GlaxoSmithKline, Pfizer, Merck, and Novartis. Show Less Read more